Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    November 2022
  1. DEMPSEY R, Ritter L, Parker L
    Strain development of A/H1N1pdm09 candidate vaccine viruses for the 2021-22 northern hemisphere influenza season.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    October 2022
  2. ZHANG RY, Pallett MA, French J, Ren H, et al
    Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-kappaB activation.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    July 2022
  3. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


  4. SEESEN M, Jearanaiwitayakul T, Limthongkul J, Sunintaboon P, et al
    Mice immunized with trimethyl chitosan nanoparticles containing DENV-2 envelope domain III elicit neutralizing antibodies with undetectable antibody-dependent enhancement activity.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    June 2022
  5. ELBEHAIRY MA, Samal SK, Belov GA
    Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    January 2022
  6. GAO WND, Gao C, Deane JE, Carpentier DCJ, et al
    The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


  7. PIADEL K, Haybatollahi A, Dalgleish AG, Smith PL, et al
    Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    October 2021
  8. WANG C, Lv L, Wu Q, Wang Z, et al
    The role of interferon regulatory factor 7 in the pathogenicity and immunogenicity of rabies virus in a mouse model.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: